Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 498 (LINC00498) is a non-coding RNA gene that does not encode a protein, but instead produces a transcript longer than 200 nucleotides located in intergenic regions of the genome[1][3][7]. Such RNAs belong to the lincRNA family, members of which are involved in regulation of gene expression at the transcriptional and epigenetic levels, fine-tuning of nearby gene activity, and can influence chromatin structure and genome architecture[5][7]. While thousands of lincRNAs have been annotated, only a small fraction, including LINC00498, have been functionally characterized, and there is limited direct evidence of it being a direct therapeutic target or clinically actionable biomarker in current literature[1][3][5]. Reasoning and clarifications: - LINC00498 is a long non-coding RNA gene and not a protein-coding gene, receptor, enzyme, or transporter[1][3][5]. Therefore, it is not recognized as a classical therapeutic target such as a receptor or enzyme. - The available references do not demonstrate LINC00498 is a validated target for approved drugs, biomarker use, or offer reports of safety concerns for modulation. - While long intergenic non-coding RNAs as a class are emerging as regulators in cancer and other diseases, many—like LINC00498—are still largely uncharacterized with respect to mechanism, clinical application, or actionable druggability[5][7]. If you need disease-specific literature or advanced experimental findings about LINC00498, further investigation in recent research databases will be necessary.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 498 (LINC00498).